ArticleBMC cancer2020

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

Kirstine Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.